Kalytera Announces Submission of Patent Application to the U.S. Patent and Trademark Office GlobeNewswire
Claims Cover Treatment of Ulcerative Colitis, Crohn’s Disease, Inflammatory Bowel Disease, GVHD and other Inflammatory Diseases of the GI Tract.